Effect of Renal Failure and Hemodialysis on Aminocaproic Acid Plasma Concentrations

M. Haug,V. F. Mauro,Hayes H. Davis
DOI: https://doi.org/10.1177/106002808902301116
1989-11-01
Abstract:TO THE EDITOR: Given the paucity of data on the use of aminocaproic acid (ACA) in patients with renal failure requiring hemodialysis, we would like to report our experiences with such a patient. A 42-year-oldwhite man with polycystic kidneydisease, previouslynever requiringhemodialysis(admissionblood urea nitrogen35 mmol/Land serum creatinine 1326IA-mollL), wasadmitted with a diagnosisof subarachnoidhemorrhage. A continuousACA intravenous infusionwasimmediately initiatedfor prophylaxisagainst rebleedingepisodes. The patient initiallyreceived the traditionaldose of 1500mg/h, butonce his renal insufficiency wasrecognized,the dose was empirically reduced to 756 rng/h. This dose was continued for nine days until 20 hours prior to discontinuing the drug when the dose was temporarily reduced to 396 mg/h. Hemodialysis therapy was started on hospital day 2 due to worseningrenal function. The patient washemodialyzedseventimes while receivingACA. Normally, the ACA infusion was continued during hemodialysis sessions; however, immediatelyprior to the sixth hemodialysissession and after the patient had been dialysis-free for nearly 44 hours (while receiving ACA 756 rng/h), the infusion was discontinued and a 3.5-hour hemodialysis performed. Venous blood was collected from the patient for ACA determinationimmediatelypreand postdialysis, and blood wascollected from the arterial and venouslinesof thehemodialysisapparatusone hourandten minutesintodialysis.The patient's hematocrit at the time of dialysis was 0.263. ACA therapy was reinstituted followingdialysis. Severaldays later,whenthe ACAtherapywasdiscontinued, blood was collected I, 8, and 24 hours after stopping the infusion. Blood samples for ACA measurement were collected in Vacutainer tubes withoutadditives, centrifuged, separated, frozen, and sent to Lederle Laboratories in Pearl River, NY. The samples were assayed by gas chromatography using a modification of a procedure described by Keucher et al.' The assay coefficientof variationwas5.8 percent, withinconcentrationsrangingfrom 33 to 420 mg/L. Blood samplescontainingconcentrationsabove this range were diluted to determine results. Total body clearance (CI) of ACA off dialysis was calculated as follows:
What problem does this paper attempt to address?